An in vitro study using the EGFR-mutant lung cancer cell lines HCC827 and H4006 co-cultured with activated peripheral blood mononuclear cells and treated with EGFR-TKIs showed notable changes in immune cell dynamics. The gene discussed is EGFR; the disease is lung carcinoma.